ALTIRATINIB

UNII:	T678746713
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₆H₂₁F₃N₄O₄
Preferred Substance Name:	ALTIRATINIB
InChIKey:	GNNDEPIMDAZHRQ-UHFFFAOYSA-N
GSRS Full Record:	T678746713 i

1345847-93-9
1,1-CYCLOPROPANEDICARBOXAMIDE, N-(4-((2-((CYCLOPROPYLCARBONYL)AMINO)-4-PYRIDINYL)OXY)-2,5-DIFLUOROPHENYL)-N'-(4-FLUOROPHENYL)-
1-N'-[4-[[2-(cyclopropanecarbonylamino)-4-pyridinyl]oxy]-2,5-difluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
1-N'-[4-[[2-(cyclopropanecarbonylamino)-4-pyridinyl]oxy]-2,5-difluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
ALTIRATINIB [USAN]
Altiratinib [WHO-DD]
DCC-2701
DP-5164
N-(4-((2-((CYCLOPROPYLCARBONYL)AMINO)PYRIDIN-4-YL)OXY)-2,5-DIFLUOROPHENYI)-N-(4- FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE
altiratinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ALTIRATINIB

Synonyms and Mappings

Resources